Takeda Pharmaceutical Company Limited Share Price
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Japan Exchange
12:00:00 30/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 6,651.00 JPY | +2.78% |
|
+4.10% | +37.56% |
| 30/10 | Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading | MT |
| 30/10 | Takeda Pharmaceutical Bets on Three New Drugs for Up to $11 Billion in Peak Sales | MT |
| Market Cap | 10,62000Cr 6.74TCr 6.04TCr 5.55TCr 5.03TCr 9.41TCr 6,40200Cr 9.58TCr 66TCr 27TCr 3,36800Cr 25TCr 25TCr | P/E 2027 * |
48.1x | P/E 2028 * | 33.1x |
|---|---|---|---|---|---|
| Enterprise Value | 14,53700Cr 9.23TCr 8.27TCr 7.6TCr 6.89TCr 13TCr 8,76300Cr 13TCr 91TCr 36TCr 4,61000Cr 35TCr 34TCr | EV / Sales 2027 * |
3.09x | EV / Sales 2028 * | 2.98x |
| Free-Float |
99.18% | Yield 2027 * |
3.07% | Yield 2028 * | 3.13% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4502 | Delayed | |
Tradegate
| TKD | Real-time | |
|
Boerse Muenchen
| TKD | Real-time | |
|
OTC Markets
| TKPHF | Delayed | |
|
Deutsche Boerse AG
| TKD | Delayed | |
|
Börse Stuttgart
| TKD | Delayed | |
|
Wiener Boerse
| TKD | End-of-day quote |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +2.78% | ||
| 1 week | +4.10% | ||
| 1 month | +15.07% | ||
| 3 months | +20.64% | ||
| 6 months | +26.20% | ||
| Current year | +37.56% |
| 1 week | 6,296 |  | 6,712 |
| 1 month | 5,606 | | 6,712 |
| Current year | 4,710 | | 6,712 |
| 1 year | 4,141 | | 6,712 |
| 3 years | 3,852 | | 6,712 |
| 5 years | 2,993 | | 6,712 |
| 10 years | 2,894.5 | | 6,712 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2025 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 61 | 01/06/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 01/01/2019 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 01/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/09/26 | Sell | Executive/Senior Manager | -34,535 | 0.0022% | ||
| 02/09/26 | Sell | Chief Technology Officer | -1,16,191 | 0.0073% | ||
| 19/08/26 | Sell | Chief Technology Officer | -19,651 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.78% | +4.10% | +60.15% | +63.70% | 6.74TCr | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,26300Cr | |
| -0.73% | +3.56% | +44.65% | +84.17% | 66TCr | |
| +1.41% | +3.24% | +35.25% | +108.88% | 52TCr | |
| +0.42% | +3.20% | +55.81% | +72.50% | 39TCr | |
| +2.18% | +2.93% | +73.90% | +45.59% | 37TCr | |
| +1.12% | +4.52% | +34.76% | +58.24% | 31TCr | |
| +6.96% | +8.86% | +11.95% | +36.20% | 29TCr | |
| +1.15% | +6.09% | +56.15% | +82.25% | 25TCr | |
| +3.06% | +9.38% | +42.48% | +117.32% | 21TCr | |
| Average | +2.15% | +5.72% | +47.94% | +82.47% | 43.29TCr | |
| Weighted average by Cap. | +2.02% | +6.56% | +50.66% | +99.86% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,70700Cr 2.99TCr 2.68TCr 2.46TCr 2.23TCr 4.17TCr 2,83700Cr 4.25TCr 29TCr 12TCr 1,49200Cr 11TCr 11TCr | 4,80600Cr 3.05TCr 2.73TCr 2.51TCr 2.28TCr 4.26TCr 2,89700Cr 4.34TCr 30TCr 12TCr 1,52400Cr 11TCr 11TCr |
| Net income | 21TCr 130.15Cr 116.57Cr 107.22Cr 97Cr 181.6Cr 12TCr 185Cr 1.28TCr 513.28Cr 6.5TCr 488.45Cr 478.07Cr | 33TCr 207.55Cr 185.88Cr 170.98Cr 154.92Cr 289.59Cr 20TCr 295.01Cr 2.04TCr 818.51Cr 10TCr 778.91Cr 762.35Cr |
| Net Debt | 3,91700Cr 2.49TCr 2.23TCr 2.05TCr 1.86TCr 3.47TCr 2,36100Cr 3.54TCr 24TCr 9.81TCr 1,24200Cr 9.33TCr 9.13TCr | 3,69300Cr 2.34TCr 2.1TCr 1.93TCr 1.75TCr 3.27TCr 2,22600Cr 3.33TCr 23TCr 9.25TCr 1,17100Cr 8.8TCr 8.61TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | JP¥6,651.00 | +2.78% | 75,82,300 |
| 29/26/29 | JP¥6,471.00 | +2.60% | 68,64,000 |
| 28/26/28 | JP¥6,307.00 | -1.56% | 39,34,400 |
| 27/26/27 | JP¥6,407.00 | -0.70% | 40,69,200 |
| 26/26/26 | JP¥6,452.00 | +0.99% | 39,33,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
